Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Biogen Inc. | 50 | 1 | 7 | 0 | €207.40 | €293.22 | 41.381% |
| Eli Lilly Corp. | 50 | 0 | 6 | 0 | €757.10 | €786.51 | 3.884% |
| Vertex Pharmaceuticals Inc. | 47 | 2 | 8 | 0 | €419.75 | €424.41 | 1.110% |
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | €138.50 | €236.30 | 70.612% |
| Regeneron Pharmaceuticals Inc. | 36 | 1 | 2 | 0 | €903.20 | €958.32 | 6.102% |
| Cytokinetics Inc. | 31 | 2 | 9 | 1 | €44.80 | €83.06 | 85.396% |
| Neurocrine Bioscience | 31 | 0 | 8 | 0 | €124.80 | €140.60 | 12.663% |
| Merck & Co. Inc. | 28 | 1 | 0 | 0 | €115.80 | €124.92 | 7.878% |
| Insmed Inc. | 28 | 2 | 15 | 2 | €49.00 | €52.40 | 6.947% |
| Pfizer Inc. | 27 | 4 | 1 | 0 | €26.42 | €40.66 | 53.897% |
| Amgen Inc. | 25 | 0 | 4 | 0 | €281.80 | €296.16 | 5.094% |
| Intra-Cellular Therapies Inc. | 25 | 0 | 2 | 0 | €62.50 | €79.55 | 27.287% |
| Trinity Biotech ADR | 24 | 0 | 2 | 0 | €0.41 | - | - |
| Zoetis Inc. A | 23 | 1 | 2 | 0 | €156.34 | €200.06 | 27.963% |
| AbbVie Inc. | 22 | 0 | 2 | 0 | €148.14 | €175.11 | 18.206% |